Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endothelial permeability regulation is a complex process involving multiple biochemical mediators that control the passage of fluids, solutes, and cells across the endothelial cell layer. Key mediators such as histamine, bradykinin, thrombin, and VEGF act through intracellular signaling pathways (e.g., RhoA/ROCK, PKC) to modulate cell-cell junctions, cytoskeletal dynamics, and extracellular matrix interactions. Disruption of this regulation contributes to various pathological conditions, including edema, sepsis, and inflammatory diseases. Therapies targeting these pathways aim to restore barrier integrity and reduce vascular leakiness.
Modulation of endothelial cell-cell junctions, cytoskeletal dynamics, and signaling pathways affecting vascular leakiness.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endothelial Permeability Regulation (N/A).